Trial intelligence / Profile preview

Prophylactic N-acetylcysteine to prevent contrast nephropathy in peripheral angiography

2005-005809-38Phase 4Completed

Sponsor
Addenbrooke's Hospital
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by Addenbrooke's Hospital. Started Jan 2006; status: completed.

02

Drugs

acetylcysteine
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on 2005-005809-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005809-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call